![]() |
|
|


Analytical Sciences, Incorporated, Statistics and Public Health Research, Durham, NC 27713;
*
Florida International University, Department of Medical Laboratory Sciences, Miami, FL 33199; U.S. Department of Agriculture/ARS, Beltsville Human Nutrition Research Center,
Food Composition Laboratory and
**
Phytonutrients Laboratory, Beltsville, MD 20705; and
Unilever Health Institute, Unilever Research, 3133 AT Vlaardingen, The Netherlands
3To whom correspondence should be addressed. E-mail: bwarden{at}asciences.com
Tea consumption has been associated with reduced risk of both cancer and cardiovascular disease in population studies, but clinical data demonstrating bioavailability of the individual catechins and other polyphenolic components of tea are limited. This study assessed the apparent bioavailability of the prominent catechins from black tea in humans drinking tea throughout the day. After 5 d of consuming a low flavonoid diet, subjects drank a black tea preparation containing 15.48, 36.54, 16.74, and 31.14 mg of (-)-epigallocatechin (EGC), (-)-epicatechin (EC), (-)-epigallocatechin gallate (EGCG) and (-)-epicatechin gallate (ECG), respectively, at four time points (0, 2, 4 and 6 h). Blood, urine and fecal specimens were collected over a 24- to 72-h period and catechins were quantified by HPLC with coularray detection. Plasma concentrations of EGC, EC and EGCG increased significantly relative to baseline (P < 0.05). Plasma EGC, EC and EGCG peaked after 5 h, whereas ECG peaked at 24 h. Urinary excretion of EGC and EC, which peaked at 5 h, was increased relative to baseline amounts (P < 0.05) and fecal excretion of all four catechins was increased relative to baseline (P < 0.05). Approximately 1.68% of ingested catechins were present in the plasma, urine and feces, and the apparent bioavailability of the gallated catechins was lower than the nongallated forms. Thus, catechins were bioavailable. However, unless they are rapidly metabolized or sequestered, the catechins appeared to be absorbed in amounts that were small relative to intake.
KEY WORDS: bioavailability catechins human study HPLC-coularray black tea
This article has been cited by other articles:
![]() |
S. Wang, S. K. Noh, and S. I. Koo Epigallocatechin Gallate and Caffeine Differentially Inhibit the Intestinal Absorption of Cholesterol and Fat in Ovariectomized Rats J. Nutr., November 1, 2006; 136(11): 2791 - 2796. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Manach, G. Williamson, C. Morand, A. Scalbert, and C. Remesy Bioavailability and bioefficacy of polyphenols in humans. I. Review of 97 bioavailability studies Am. J. Clinical Nutrition, January 1, 2005; 81(1): 230S - 242S. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. P Mulder, A. G Rietveld, and J. M van Amelsvoort Consumption of both black tea and green tea results in an increase in the excretion of hippuric acid into urine Am. J. Clinical Nutrition, January 1, 2005; 81(1): 256S - 260S. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Halliwell, J. Rafter, and A. Jenner Health promotion by flavonoids, tocopherols, tocotrienols, and other phenols: direct or indirect effects? Antioxidant or not? Am. J. Clinical Nutrition, January 1, 2005; 81(1): 268S - 276S. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. M Henning, Y. Niu, N. H Lee, G. D Thames, R. R Minutti, H. Wang, V. L. W Go, and D. Heber Bioavailability and antioxidant activity of tea flavanols after consumption of green tea, black tea, or a green tea extract supplement Am. J. Clinical Nutrition, December 1, 2004; 80(6): 1558 - 1564. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. B. M. van Duursen, J. T. Sanderson, P. Chr. de Jong, M. Kraaij, and M. van den Berg Phytochemicals Inhibit Catechol-O-Methyltransferase Activity in Cytosolic Fractions from Healthy Human Mammary Tissues: Implications for Catechol Estrogen-Induced DNA Damage Toxicol. Sci., October 1, 2004; 81(2): 316 - 324. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. A Kroon, M. N Clifford, A. Crozier, A. J Day, J. L Donovan, C. Manach, and G. Williamson How should we assess the effects of exposure to dietary polyphenols in vitro? Am. J. Clinical Nutrition, July 1, 2004; 80(1): 15 - 21. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Manach, A. Scalbert, C. Morand, C. Remesy, and L. Jimenez Polyphenols: food sources and bioavailability Am. J. Clinical Nutrition, May 1, 2004; 79(5): 727 - 747. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. S. Wheeler, J. D. Catravas, K. Odoms, A. Denenberg, V. Malhotra, and H. R. Wong Epigallocatechin-3-gallate, a Green Tea-Derived Polyphenol, Inhibits IL-1{beta}-Dependent Proinflammatory Signal Transduction in Cultured Respiratory Epithelial Cells J. Nutr., May 1, 2004; 134(5): 1039 - 1044. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. B. Vaidyanathan and T. Walle Cellular Uptake and Efflux of the Tea Flavonoid (-)Epicatechin-3-gallate in the Human Intestinal Cell Line Caco-2 J. Pharmacol. Exp. Ther., November 1, 2003; 307(2): 745 - 752. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Frank, T. Lundh, R. S. Parker, J. E. Swanson, B. Vessby, and A. Kamal-Eldin Dietary (+)-Catechin and BHT Markedly Increase {alpha}-Tocopherol Concentrations in Rats by a Tocopherol-{omega}-Hydroxylase-Independent Mechanism J. Nutr., October 1, 2003; 133(10): 3195 - 3199. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. J Murphy, A. K Chronopoulos, I. Singh, M. A Francis, H. Moriarty, M. J Pike, A. H Turner, N. J Mann, and A. J Sinclair Dietary flavanols and procyanidin oligomers from cocoa (Theobroma cacao) inhibit platelet function Am. J. Clinical Nutrition, June 1, 2003; 77(6): 1466 - 1473. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. B. Vaidyanathan and T. Walle Glucuronidation and Sulfation of the Tea Flavonoid (-)-Epicatechin by the Human and Rat Enzymes Drug Metab. Dispos., August 1, 2002; 30(8): 897 - 903. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Rumpler, J. Seale, B. Clevidence, J. Judd, E. Wiley, S. Yamamoto, T. Komatsu, T. Sawaki, Y. Ishikura, and K. Hosoda Oolong Tea Increases Metabolic Rate and Fat Oxidation in Men J. Nutr., November 1, 2001; 131(11): 2848 - 2852. [Abstract] [Full Text] [PDF] |
||||